“The company’s Australian chief executive Rohan Hockings said there were about 50 people with the condition in Perth.“There’s a well-characterised, identified patient population here in Perth with this disease and they don’t have any treatment options today,” Dr Rohan said.”
regulatory validation milestone achieved! well done all - good coverage by the local paper - looks like patients are lined up for clinical trials:
https://thewest.com.au/news/health/pyc-therapeutics-lands-fda-clearance-for-retinitis-pigmentosa-treatment-drug-c-9952698.amp
Ann: FDA Clears PYC to Commence First Human Trials in RP11, page-20
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.30 |
Change
-0.025(1.89%) |
Mkt cap ! $755.3M | |||
| Open | High | Low | Value | Volume |
| $1.32 | $1.32 | $1.30 | $478.1K | 365.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $1.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.32 | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |